Alan H. Matsumoto, MD, chair of the department of radiology at the University of Virginia and vice chair of the American College of Radiology Board of Chancellors, explains the contrast shortage situation and the tough decisions providers are being forced to make.

The company says the approval for ablations will allow interventional radiologists to perform these operations with nonlinear steering that facilitates high accuracy and average skin-to-target times under nine minutes.

Another teaching hospital has quickly and safely reduced its reliance on iodinated contrast media (ICM) by around 50% and taken to the pages of JACR to tell how they did it.

“We need to commit to changing the supply chain so that a single event in a faraway country does not put us in this predicament again," experts wrote in a new special report shared by Radiology.

Researchers at a quaternary academic medical center have developed a short-term workaround that they report is now reducing the institution’s consumption of Omnipaque (iohexol) by more than 50% without compromising care quality.

The COVID lockdowns at the Shanghai plant began on March 31, and although the plant there has since resumed operations, they are not yet at 100% capacity.

The American Hospital Association is asking GE Healthcare to more fully apprise AHA’s nearly 5,000 member organizations of what the company is doing to help ameliorate the ongoing disruption in supplies of Omnipaque (iohexol).

U.S. healthcare is now a solid week into the CT contrast shortage of ’22, and common themes are emerging in adaptations at local hospitals and imaging centers.